Irwin Federman

Irwin Federman has an estimated net worth of $16.8 Million. This is based on reported shares across multiple companies, which include LEADIS TECHNOLOGY INC, OCCAM NETWORKS INC/DE, Altus Pharmaceuticals Inc., AT ROAD INC, Mellanox Technologies, Ltd., IMPERVA INC, Guidewire Software, Inc., NUANCE COMMUNICATIONS, CASTLIGHT HEALTH, INC., CENTILLIUM COMMUNICATIONS INC, Inari Medical, Inc., ON24 INC., Inspire Medical Systems, Inc., ChaSerg Technology Acquisition Corp, Intersect ENT, Inc., AtriCure, Inc., MAXLINEAR INC, BOX INC, SANDISK CORP, OncoMed Pharmaceuticals Inc, INTERMOLECULAR INC, CURON MEDICAL INC, and NETRO CORP.

2015 was Irwin Federman's most active year for acquiring shares with 11 total transactions. Irwin Federman's most active month to acquire stocks was the month of April. 2005 was Irwin Federman's most active year for disposing of shares, totalling 10 transactions. Irwin Federman's most active month to dispose stocks was the month of April. 2005 saw Irwin Federman paying a total of $1,853,806.60 for 82,750 shares, this is the most they've acquired in one year. In 2020 Irwin Federman cashed out on 45,965 shares for a total of $5,745,625.00, their largest year based on trade value.